Showing 511-520 of 854 results for "".
- Galderma Establishes new US Headquarters in Florida to Strengthen Regional Leadershiphttps://modernaesthetics.com/news/galderma-establishes-new-us-headquarters-in-florida-to-strengthen-regional-leadership/2475385/Galderma announced Tuesday the company is establishing a new US headquarters in Miami, Florida. The new location aims to position Galderma at the heart of a thriving market for Dermatological Skincare and Injectable Aesthetics. The headquarter will be in the Brickell neighborhood
- Midmark Announces First USAB Compliant Procedure Chairhttps://modernaesthetics.com/news/midmark-announces-first-usab-compliant-procedure-chair/2475384/Midmark Corp. announced the launch of the Midmark 631 procedure chair, which the company said is the first US Access Board (USAB) compliant procedure chair. In 2024, the U.S. Access Board issued a new standard establishing design criteria for examinati
- GALDA Co-Director Explains Organization's Work and Impacthttps://modernaesthetics.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://modernaesthetics.com/news/ab-chopra-epigenetics-launches-with-plan-to-revolutionize-longevity/2475380/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Dr. CI:Labo Presents New Clinical Data on Post-IPL Skincare for Asian Skin at IMCAS Asia 2025https://modernaesthetics.com/news/dr-cilabotm-presents-new-clinical-data-on-post-ipl-skincare-for-asian-skin-at-imcas-asia-2025/2475378/At IMCAS Asia 2025, Dr.CI:LABOTM presented new clinical findings demonstrating the efficacy of two of its skincare products—VC100 Essence Lotion EX and 377VC Radiance Serum—as adjuncts to Intense Pulsed Light (IPL) treatments in Asian patients. The data reve
- New Artificial Intelligence Platform to Enhance Leads, Conversions, and Retention for Private-Pay Clinicshttps://modernaesthetics.com/news/new-artificial-intelligence-platform-to-enhance-leads-conversions-and-retention-for-private-pay-clinics/2475367/BoomerangFX announced the global launch of LeadEngineAITM, an AI-powered platform designed to streamline and automate lead generation and conversion for private-pay healthcare cli
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://modernaesthetics.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Allergan Aesthetics Appoints Inaugural AMI Training Center Facultyhttps://modernaesthetics.com/news/allergan-aesthetics-appoints-inaugural-ami-training-center-faculty/2475356/Allergan Aesthetics, an AbbVie company, has introduced the first faculty cohort for its new Allergan Medical Institute® (AMI) Training Centers in Orange County, CA, and Atlanta, GA. The new AMI Training Center Faculty will lead immersive educational programs designed to train and support the
- ASLMS 2025: E. Victor Ross, MD, Talks Landscape of Fractional Laser Treatmentshttps://modernaesthetics.com/news/aslms-2025-e-victor-ross-md-talks-landscape-of-fractional-laser-treatments/2475359/At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations. Risk, Recovery, and Pigmenta
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick